Aims: Since lupus nephritis (LN) etiopathogenesis is not fully understood, herein we investigated the morphological basis of LN in mice induced with pristane. Main methods: To evaluate the melatonin effects in these animals, we studied the renal cytoarchitecture by means of morphological analyses, immunofluorescence expression of specific markers related to fibrosis, oxidative stress, inflammation and apoptosis. Key findings: We observed that pristane-LN mice have serious alterations in the kidney cytoarchitecture, i.e. tubular degeneration, glomerular hypercellularity, matrix mesangial expansion and interstitial inflammation. The pristane-induced LN mice treated with melatonin exhibited a well preserved cytoarchitecture. Significance: Our results document that LN etiopathogenesis is related to both tubular damage and glomerular lesions. We suggest that it is essential to take in consideration both these lesions for LN diagnosis and classification. Clearly, we show that the use of melatonin may be a possible therapeutic strategy for improvement the renal injury in this disorder.
Introduction
Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus (SLE), occurring in approximately half of SLE patients with high morbidity and mortality [1] . LN is characterized by proteinuria, hematuria and cellular casts, potentially leading to endstage renal failure and to the requirement for dialysis or renal transplantation [2, 3] . LN without treatment damages the kidney parenchyma which is then replaced by fibrotic tissue [4] . Moreover, LN has also been associated with an imbalance between oxidative and antioxidative activities leading to oxidative stress as a result of reactive oxygen species and reactive nitrogen species overproduction [5] .
The current therapies used to treat SLE, including glucocorticoids and cyclophosphamide, suppress humoral immunity and the production of autoantibodies as well as helper T cells and B lymphocytes [6] . The objective of recent studies has been to treat patients in a personalized strategic manner that ameliorates long-term outcomes. Thus, efforts to identify and promote new therapeutic strategies that improve the course of disease or reverse its activity period, without causing collateral damage to unaffected tissues and organs, are urgently needed [7] .
There are several SLE animal models that play an important role in investigating the mechanisms of this disease. One model is the pristaneinduced lupus mouse model; these animals exhibit many clinical features of human lupus [8, 9] , developing significant proteinuria and kidney alterations consistent with the diffuse proliferative form of LN [9] [10] [11] . These symptoms observed in pristane-induced LN animal model lead to a significant alteration of renal function [12, 13] . In detail, these mice have disparate T cell requirements of two subsets of lupus-specific autoantibodies as well as the toll-like receptor 7 (TLR7)-dependent and Fcγ receptor-independent production of type I interferon [7, 10] . TLR7 is strictly involved in the production of autoantibodies and the development of LN [6, 11] . Moreover, consistent with the findings in humans, CD41 T cells and cytokines, play a pro-inflammatory role in pristaneinduced LN [14] . Furthermore, a wide variety of autoantibody reactivity has been detected in patients with SLE [15] and the pristane-induced LN mice showed elevations in autoantibodies against many RNA-associated antigens, such as U1-snRNP complexes and RiboP [9] . Therefore the pristane-LN mice model has important relevance to human disease [8, 15] .
Melatonin is a suitable and useful therapy for many conditions because of its multitasking properties [16] . Melatonin is a proven safe and remarkably well-tolerated indoleamine particularly known for its antioxidant properties [16] [17] [18] . In addition to its antioxidant properties, melatonin also is antifibrotic and modulates apoptosis [19, 20] . Melatonin has been used for the treatment of various experimental fibrotic diseases, including fibrotic renal diseases [21] [22] [23] , pulmonary hypertension [24] , liver fibrosis [22] and hypertrophic scar [21] . Interestingly, melatonin not only significantly attenuates fibrosis, but also improves organ physiology [21] . Accompanying the inhibition of renal fibrosis, melatonin also reduced leukocyte infiltration, via reduction in the expression of pro-inflammatory markers [23] , and significantly reduces the apoptotic mechanisms after an acute unilateral ureteral obstruction [25] and in cardiorenal syndrome [26] . Ramamoorthy et al. observed that melatonin pretreatment inhibited NF-kB and protected against tenofovir disoproxil fumavate-induced renal damage [18] .
Since the LN etiopathogenesis is not fully understood, we investigated its morphological basis; to do so, we examined the involvement of fibrosis, oxidative stress, inflammation and apoptosis in this disease at the level of the kidney. Then, we evaluated whether melatonin is effective and its possible mechanism(s) of action in LN treatment.
The findings provide evidence that melatonin restores renal morphological alterations preventing induction of fibrosis, oxidative stress and inflammation. Interestingly, regarding the effect of melatonin on apoptosis, we demonstrate that it modulates differently the apoptotic pathway in glomerular and tubular cells. Thus, we suggest that melatonin may be a valuable therapeutic alternative strategy for minimizing the kidney injury related to LN pathological processes.
Materials and methods

Experimental design
Fifty female mice BALB/c, at 8 weeks of age, were obtained from Federal University of Pelotas (Pelotas, Brazil). The care of animals used in the present study followed local and international guidelines in accordance also with the recommendations by the Research and Ethics Committee on Health Research Group and Graduate Studies of Clinical Hospital of Porto Alegre (Brazil).
BALB/c mice were randomly divided into the following five groups (ten animals per group): 1) Pristane-induced LN mice, which received 500 μl of pristane (Sigma Aldrich, MO, USA) intraperitoneally [11] [12] [13] ; 2) Control mice, which received 500 μl of saline intraperitoneally (pristane vehicle); 3) Melatonin vehicle mice treated for six months with 1% ethanol dissolved in drinking water; 4) Melatonin control mice treated for six months with melatonin (10 mg/kg/day) dissolved in 1% ethanol and then in drinking water; 5) Pristane-induced LN mice treated for six months with melatonin (10 mg/kg/day) dissolved in 1% ethanol and then in drinking water; melatonin treatment began one day after pristane induction.
Animals were killed and the kidneys were removed for the following morphological, immunofluorescence, immunoenzymatical and ultrastructural analysis. For morphological and immunofluorescence analyses, the kidneys were dehydrated in ethanol and embedded in paraffin wax, following standard protocol. Then, the samples were sectioned using a microtome (7 μm of section thick). Moreover, for the ultrastructural analysis pieces of renal tissue were removed and fixed in 2.5% glutaraldehyde in cacodylate buffer 0.1 M and post-fixed in 1% osmium tetroxide, dehydrated in graded ethanol, incubated in propylene oxide and finally embedded in Epon mixture resin.
Haematoxylin-eosin staining
Histomorphological analysis of kidneys can be used to confirm and characterize nephritis severity [15, 27] . Alternate paraffin-embedded sections were deparaffined, rehydrated and finally stained with haematoxylin-eosin staining, according to standard procedures. The stained sections were observed with a light microscopy (Olympus, Germany) at a final magnification of 400×, then the histopathological glomerular injury score was obtained, as reported by Furumoto et al. [28] . To this score we added also the assessment of tubular alterations. A minimum of 30 random kidney areas for each experimental animal were analyzed and for each section a score from (−) to (++++) was assigned separately for glomeruli, proximal and distal tubules: (−): no alteration; (+/−) weak alteration, (+): mild alteration, (++): moderate alteration, (+++): marked alteration and (++++): extreme alteration. Scores from each individual mouse were averaged to yield the glomerular, proximal and distal tubules morphological injury scores of each experimental group.
The percentage of inflammatory infiltration at 100 random kidney fields was also calculated for each experimental animal. Furthermore, the glomerular cellularity was quantified by counting the total cell nuclei per glomerulus (at least 30 glomeruli for 5 sections for each experimental animal) and also a minimum of 50 randomly chosen glomeruli were evaluated to detect the class of LN lesion, following the LN classification proposed by Weening et al. [29] . All measurements and analyses were performed in a blind fashion and using an image analyzer (Image Pro Premier 9.1, MediaCybernetics Inc., Rockville USA). Finally, pristane induction of LN was monitored histomorphologically in each experimental groups assigning an histological grade of progression from 0 to 4, as previously reported also by Bender et al. [15] . Key points of the histomorphological grading system were as follows: grade 0-1: normal renal cytoarchitecture; grade 2: minimal change characterized by weak glomerular hypercellularity, mesangial matrix broadening, capillary alterations and inflammatory cell infiltration; grade 3: moderate to marked change of much greater severity than grade 2, often affecting the majority of glomeruli together with moderate tubular dilatation and protein casts and grade 4: severe changes affecting the majority of glomeruli (often accompanied by glomerulosclerosis) and tubules.
Picrosirius red staining
Picrosirius red staining was used to quantify renal interstitial collagen deposition [30] . Randomly chosen 50 renal fields for each experimental animal were observed with a light microscopy (Olympus, Germany) at a final magnification of 400 × and in a blind manner. The determination of the different types of collagen content (percentage of area) was calculated using a computerized image analysis system (Image Pro Premier 9.1, Media Cybernetics Inc., Rockville USA), as previously reported by Bonomini et al. [31] and Rizzoni et al. [32] .
Periodic acid Schiff (PAS) staining
Alternate embedded-paraffin sections were stained with PAS staining to detect intraglomerular mesangial proliferation and also proximal tubule brush boarder alterations [30, 33] . For each experimental animal, a minimum of 50 randomly chosen renal fields were analyzed with a light microscopy (Olympus, Germany) at final magnification of 400 × and, using a computerized image analysis system (Image Pro Premier 9.1, Media Cybernetics Inc., Rockville USA), we measured the pink staining separately at glomerular and proximal tubules level. All measurements and analysis were performed in a blind fashion.
Immunofluorescence analysis
Kidney sections were processed for the immunofluorescence analyses of these primary antibodies (Santa Cruz Biotechnology, Inc., USA): anti-rabbit superoxide dismutase1 -SOD1 (diluted 1:200), anti-goat catalase -CAT (diluted 1:200), anti-mouse tumor growth factor-beta 1 -TGF-β1 (diluted 1:250), anti-goat interleukin-6 -IL-6 (diluted 1:200) and anti-rabbit Bax (diluted 1:200), following the immunofluorescence protocol and the histomorphometrical analysis reported previously by Agabiti-Rosei et al. [34] and Oliveira et al. [35] .
Kidney interleukin-6 (IL-6) evaluation
The kidneys were homogenized, lysated and so subjected also to analyses of the levels of IL-6 using a specific ELISA assay kit and following the manufacturer's instruction (Abcam, Cambridge, UK).
Ultrastructural analysis
Ultrathin sections (70-80 nm of section thick) were processed for ultrastructural analyses using a transmission electron microscopy (TEM CM10 FEI), as previously reported by Favero et al. [36] and Stacchiotti et al. [37] .
Statistical analysis
The data are expressed as mean ± standard error of the mean (SEM). Data for multiple variable comparisons were analyzed by oneway analysis of variance (ANOVA corrected Bonferroni test). p ≤ 0.05 is considered significant for all statistical analysis performed in this study.
Results
Haematoxylin-eosin staining
We detected pathologic nephritic features at both the glomerular and tubular level, through the assessment of glomerular hypercellularity, renal inflammation and tubular degeneration characterized by also loss of epithelial cells or by proteins and/or mononuclear cells deposition in and narrowing the tubular lumen.
In the control groups treated with saline (vehicle of pristane) or treated with melatonin or melatonin vehicle (1% ethanol) there were no obvious kidney alterations. These results underline that these experimental groups are similar, so they are defined generically as "control mice" for the following morphological, histomorphometrical, immunoenzymatical and ultrastructural analysis.
There were also no differences in the renal cytoarchitecture between pristane-LN mice treated or not with 1% ethanol. So, both experimental groups are considered generically as "pristane-LN mice" for the following morphological, histomorphometrical, immunoenzymatical and ultrastructural analysis.
Pristane-LN mice exhibited kidney morphological damage relative to control mice. The damage observed in kidneys of pristane-LN mice involved inflammatory infiltration, glomerular mesangial cell proliferation, sclerosis of glomerular tuft (Fig. 1A) , enlarged tubular epithelium, tubular lumen filled with protein aggregates and proximal tubules were often devoid of a brush border (Fig. 1B) with respect to kidneys of control mice (Fig. 1C, D) . Kidneys of pristane-LN mice treated with melatonin showed a significant improvement of the cytoarchitecture, at both glomerular (Fig. 1E ) and proximal and distal tubular (Fig. 1F) level.
The glomerular and tubular morphological injury scores are summarized in Table 1 . Since there are no significant morphological differences between proximal and distal tubules, we show the overall scores titled generically as "tubules".
Kidney of pristane-LN mice showed also a significant percentage of inflammatory cell infiltration (Fig. 1A, B) relative to those in kidneys of control mice (Fig. 1C, D) ; the latter showed absent/very weak inflammatory infiltration. Kidneys of pristane-LN mice treated with melatonin had a significant reduction of inflammatory infiltration (Fig. 1E, F) . These observations are summarized in Table 2 .
Pristane-LN mice showed significant increased of glomerular cellularity after 5 months of LN induction with compared to control mice. The treatment of pristane-LN mice with melatonin reduced significantly the glomerular hypercellularity. These observations are summarized in Fig. 1G .
Kidneys of pristane-LN mice exhibited mesangial broadening followed by global endo-or extra-capillary glomerulonephritis involving > 50% of total glomeruli. These observations consisted of diffuse proliferative LN, identify as Class IV-G LN. Interestingly, kidneys of pristane-LN mice treated with melatonin showed only mild mesangial broadening and few isolated subendothelial deposits, as typical of Class II LN.
Remarkably, pristane-LN mice exhibited a histomorphological profile of nephritis progression characterized by marked renal alterations, identified with grade 3, significant higher respect the degree of injury observed in the control mice (grade 0). The treatment with melatonin of pristane-LN mice showed a significant reduction of this histomorphological score, showing a histomorphological degree of LN progression < 2.
Sirius red staining
Sirius red morphometrical evaluation revealed that kidneys of pristane-LN mice exhibited a significant increase of tubular interstitial collagen deposition relative to kidneys of control mice, which showed absent/very weak interstitial collagen deposition. Kidneys of pristane-LN mice treated with melatonin had a significant reduction of tubular interstitial collagen deposition, restoring the "normal" kidney collagen deposition. Furthermore, we observed that type I collagen was significantly greater in kidneys of pristane-LN mice with respect to kidneys of control mice and, as for total collagen deposition, melatonin treatment showed a significant reduction of renal type I collagen. Type III collagen amount was not significantly different among the experimental groups studied.
The Fig. 2 summarizes the date reported above.
PAS staining
PAS staining revealed that kidneys of pristane-LN mice had an intense intraglomerular mesangial cell broadening (Fig. 3A) and proximal tubules devoid of brush border. Moreover, both proximal and distal tubules showed a reduction of epithelial cells (Fig. 3B) . Kidneys of control mice exhibited absent/very weak mesangial matrix expansion (Fig. 3C ) and normal cytoarchitecture of proximal and distal tubules; in detail, proximal tubules showed regular PAS-positive brush border (Fig. 3D) . Interestingly, mesangial cell expansion was significantly reduced in kidneys of pristane-LN mice treated with melatonin (Fig. 3E) . Melatonin prevented also the major alterations in proximal tubules, preserving the brush border that had a moderate PAS-positive staining like normal structures. Moreover, melatonin decreased the reduction of epithelial cells both in proximal and distal tubules (Fig. 3F) .
The Fig. 3G summarizes the morphometrical analysis of both intraglomerular mesangial matrix and proximal tubules brush border PAS-positive stainings.
Kidney expression of TGF-β1 (green staining) was evaluated to better investigate the pro-fibrotic pathway involved in LN kidney injury. Kidneys of pristane-LN mice showed a moderate/strong expression of TGF-β1, respectively, at glomerular and both proximal and distal tubules level (Fig. 4A) , compared to kidneys of control mice that showed absent/very weak expression at glomerular, proximal and distal tubules (Fig. 4B) . On the other hand, melatonin treatment of pristane-LN mice induces a significant renal reduction of the expression of this pro-fibrotic marker, showing very weak/weak expression at glomerular, proximal and distal tubular level (Fig. 4C ).
These observations were confirmed also by the histomorphometrical analysis at glomerular, proximal and distal tubular level (Fig. 4D) . Since there were no significant differences between TGF-β1 proximal and distal tubular expressions, we show in the graph the mean value define generically as "tubules".
Immunofluorescence analysis of CAT (identified in green) showed a significant reduction of its expression in kidneys of pristane-LN mice at glomerular, proximal and distal tubules level (weak expression) ( Fig. 5A ) with respect to kidneys of control mice showing weak/moderate expression at glomerular level and strong expression at both proximal and distal tubular level (Fig. 5B) . Furthermore, kidneys of pristane-LN mice treated with melatonin showed a significant increase of CAT expression at glomerular, proximal and distal tubular level (Fig. 5C) .
We investigated also the antioxidant enzyme SOD1 (identified in red) and we observed a trend similar to that observed for CAT. In other words, kidneys of pristane-LN mice had a weak SOD1 expression at glomerular and tubular level (both proximal and distal tubules) ( Fig. 5D ) with respect to kidneys of control mice showing weak/moderate expression at glomerular level and strong expression at both proximal and distal tubular level (Fig. 5E) . Kidneys of pristane-LN mice treated with melatonin showed a significant increase of SOD1 expression at glomerular, proximal and distal tubular level (Fig. 5F ).
All the observations reported above were confirmed also by the histomorphometrical analysis of renal CAT (Fig. 5G) and SOD1 (Fig. 5H) at glomerular, proximal and distal tubular level. Since there were no significant differences between both CAT and SOD1 proximal and distal tubular expressions, we display in the graphs the mean values define generically as "tubules".
To investigate also inflammation and apoptosis in LN pathogenesis, the kidney expression of IL-6 (green staining) and Bax (red staining) are evaluated. Kidneys of pristane-LN mice showed a moderate/strong expression of IL-6 inflammatory enzyme at glomerular and both proximal and distal tubules level (Fig. 6A ) with respect to kidneys of control mice (absent/very weak expression) (Fig. 6B) . Melatonin treatment of pristane-LN mice exhibited a significant reduction of the renal expression of IL-6 at glomerular and tubular level (both proximal and distal tubules), (Fig. 6C) .
Kidneys of pristane-LN mice also had a moderate/strong expression of the pro-apoptotic marker Bax at glomerular and tubular level (both proximal and distal tubules) (Fig. 6D) , with respect to kidneys of control mice that showed absent/weak expression at glomerular, proximal and distal tubules level (Fig. 6E) . Interestingly, kidneys of pristane-LN mice treated with melatonin showed a weak expression of Bax at both proximal and distal tubular level, but a moderate expression at glomerular level (Fig. 6F) .
These observations were confirmed also by the histomorphometrical analysis of renal IL-6 (Fig. 6G) and Bax (Fig. 6H) at glomerular, proximal and distal tubular level. Since there were no significant differences between both IL-6 and Bax proximal and distal tubular expressions, we show in the graphs the mean values define generically as "tubules".
Kidney interleukin-6 (IL-6) evaluation
As summarized in Fig. 7 , the ELISA evaluation of kidney IL-6 confirmed the data obtained through the histomorphometrical analyses. In brief, pristane-LN mice showed a higher IL-6 kidney concentration respect to control mice, that had weak renal IL-6 level. Remarkably, melatonin treatment of pristane-LN mice reduced significantly kidney IL-6, reaching concentration value comparable to kidney of control mice.
Ultrastructural analysis
Using ultrastructural analysis, we evaluated glomerular, proximal and distal tubular features in different experimental groups. Kidneys of pristane-LN mice showed important glomerular damage: evident foot process effacement, basal membrane thickening, apoptotic mesangial cells with condensed nuclei, typically of apoptotic cells, and matrix broadening (Fig. 8A) . Ultrastructural features of tubular oxidative damage and interstitial fibrosis were apparent in kidneys of pristane-LN mice together with apoptotic cells in both proximal and distal tubules (Fig. 8B) . In the proximal tubules we noted also brush border detachment and, in particular, abnormal mitochondria with disrupted cristae, as it is evident in Fig. 8C . Also, distal tubules showed basal labyrinth folding often filled with round mitochondria devoid of cristae and an amorphous matrix (data not showed). On the other hand, kidneys of control mice presented well-defined renal ultrastructure showing also, in proximal and distal tubules, that the mitochondrial shape was elongated and the cristae were well preserved (data not showed). When we analyze kidney of pristane-LN mice treated with melatonin the glomerular tuft showed almost regular organization, well preserved foot processes of podocytes, limited mesangial matrix broadening, but also apoptotic mesangial nuclei (Fig. 8D) . Remarkably, proximal and distal tubules showed a "normal" ultrastructure features and, in particular, proximal tubules have a regular and continuous brush border (Fig. 8E) . Furthermore, proximal and distal tubules showed numerous, well preserved and elongated mitochondria with clear cristae. Fig. 8F shows restored proximal tubular mitochondria.
Discussion
The renal alterations induced by pristane in this mouse model were severe and were significantly reduced by melatonin co-treatment. We evaluated the renal alterations caused by a single intraperitoneal pristane injection, through morphological analyses and immunohistochemical expression of specific markers related to fibrosis, oxidative stress, inflammation and apoptosis.
We observed that pristane-LN mice have serious alterations in the kidney cytoarchitecture and confirmed that these animals exhibit many features of human LN [8] . Similar results have been recorded in previous studies in which LN mice had morphological alterations such as glomerulonephritis, characterized by mesangial broadening, hypersegmentation and sclerosis of glomerular tufts [9, 33, 34] . In particular, according to Gardet et al. the lesions are related to prominent kidney interstitial inflammation and fibrosis, which were both associated with poor prognosis in human LN [38] . These data confirm the sharing of many histopathologic features of human LN [8, 39] .
Significant tubular injury, ranging from enlarged epithelial cells to 
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interstitial fibrosis, was observed in the current study. Tubular epithelial cells interact with inflammatory cells secreting pro-inflammatory mediators, including monocyte chemoattractant protein 1, CD40, and Toll-like receptor 9 [40] eliciting a variety of responses to protein overload. In fact, an increasing amount of data supports that tubular lesions are predictive of progression in renal disease strongly indicating the decline in the function of the organ [41, 42] . Further, these latter authors highlighted the importance of interstitial processes in determining prognosis of this disease. Paradoxically, these tubular lesions are not considered in the current classification of Weening et al. [29] , as also previously reported [43] . So, we suggest that it is very important to take in consideration not only glomerular lesions, but also tubulointerstitial alterations in predicting renal outcome. LN involves the release of pathogenic mediators which worsen glomerular mesangial and tubular epithelial cell damage, such as inflammatory cytokines and reactive oxygen species [5, 40] . The role of these pathological processes in the triggering of the LN disease is yet to be determined. Regarding these findings, we observed a significant reduction of the expression of CAT and SOD1 antioxidants in pristane-LN mice, these data are in agreement with human clinical evidences that showed an increased of reactive oxygen species production and an inadequate endogenous antioxidant defense of patients with LN [44] . Furthermore, we noted in pristane-LN mice a significant rise of TGF-β1 and IL-6 expressions at both glomerular and tubular levels, as also previously observed also in human [45] [46] [47] . These authors demonstrated that, in chronic progressive renal disease, TGF-β1 and IL-6 signalings are part of a conceptual framework consolidating pathomechanisms of the progression of glomerular and tubulointerstitial disease.
It is known that TGF-β1 is considered as a main factor in the promotion of epithelial-to-mesenchymal transdifferentiation, which induces renal fibrosis [48] . Moreover, glomerular morphological injury is a potent inducer for IL-6 generation in tubular epithelial cells, which presents one aspect of glomeruli-tubules cross talk [49] . The inflammatory infiltration in the tubular interstitium and in the glomeruli, a prominent feature in both human and mice LN, induces the secretion of inflammatory cytokines and chemokines that contribute to the apoptosis of both glomerular mesangial cells and tubular epithelial cells [10, 50, 51] .
Considering the critical role of apoptosis in the development and outcomes of kidney diseases [50, 52] , we investigated also Bax, a proapoptotic marker [53, 54] . In pristane-LN mice Bax expression was elevated in renal tubular epithelial cells and moderately in glomerular mesangial cells, with respect to control mice who showed very weak renal Bax expression. These data are in agreement with the previous study of Cui et al. who observed a Bax expression in glomerular parenchymal cells and tubular epithelial cells of LN patients [55] . In addition to an adequate LN animal model that is needed for the identification of markers related to pathogenesis, increasing research efforts are required to understand the molecular mechanisms underlying kidney injury to identify new therapeutic approaches. Thus, the present study also evaluated the effects of melatonin treatment against kidney injury induced by LN. Melatonin treatment of pristane-LN mice lessened morphological lesions caused by LN pathogenesis, restoring a "normal" renal morphology and cytoarchitecture. In fact, pristane-LN mice treated with melatonin showed a significant increase of the expression of CAT and SOD1 at proximal and distal tubular level. We suggest that the treatment suppressed kidney LN alterations through indirect inhibition oxidative injury of tubules, due to the well known antioxidant melatonin ability [13, 14, 56] .
Melatonin treatment also significantly lowered TGF-β1 expression and, consequently, reduced the mesangium broadening and hampered tubular apoptosis and interstitial fibrosis. These observations are in agreement with previous reports indicating that melatonin has important antifibrotic effect in various experimental fibrotic conditions [21, 22] .
We observed also that melatonin treatment determined a significant renal decrease of the IL-6 expression and a specific Bax modulation. These results are consistent with a previous report of Zhou et al., which showed that pristane-induced lupus mice display an imbalance of cytokine network with increasing level of IL-6 that, in turn, induces B cells to secret more antibodies and promote the development of nephritis [57] . Furthermore, these authors showed that the downregulation of IL-6 production by melatonin was helpful in inhibiting renal damage in this animal model. The effect on Bax expression could be due to its direct anti-apoptotic properties [20, 25, 26, 33, 56] or to its indirect action in counteracting, as previously reported, inflammation and fibrosis that, in turn, does not promote the apoptotic pathway. It is important to underline that melatonin treatment of pristane-LN mice showed, also, a moderate expression of Bax at glomerular level. This is important because the defective clearance of apoptotic debris may sustain and accelerate autoimmunity, mesangial broadening and kidney inflammation [18, 28] . In particular, the observation on Bax glomerular expression may be related on the melatonin attempt to eliminate activated and proliferating mesangial cells through apoptosis, allowing the return of the "normal" renal cytoarchitecture due to the multitasking melatonin properties [16, 58] .
Recently other novel approaches for the management of LN using antioxidant compounds, such as salvianolic acid A and resveratrol, have been studied in the same LN animal model [6, 11] . These studies suggested the potential effects of these compounds in alleviating LN renal dysfunction and histological damages mainly at glomerular level. The current study provides convincing evidence about the efficacy of melatonin treatment in attenuating and ameliorating the progression kidney LN-induced injury, showing that, together with the important antioxidant melatonin mechanism of action, part of the beneficial effects of this indoleamine are due to the protection of also tubular epithelial cells and to its particular pro-and anti-apototic effects. This was especially obvious considering that melatonin-induced apoptosis at mesangial cell level may be a response to counteract mesangium proliferation in LN. These results underline the fundamental opposite proand anti-apoptotic melatonin effects as previously reported by also Bizzarri et al. [59] and Reiter et al. [16] . These authors suggest that melatonin has a pro-apoptotic action against cancer cells but also a diametrically opposite anti-apoptotic function in normal cells.
Conclusions
In summary, we suggest that melatonin oral treatment, at the final dose of 10 mg/kg/day, via its important antifibrotic, antioxidative, antiinflammatory and dual and opposite pro-and anti-apoptotic effects may block LN-related kidney injury (Fig. 9) . However, further studies are necessary to establish the more effective dose of melatonin and to better understand the melatonin mechanism(s) of action and regulating process(es). . Lupus nephritis kidney injury and melatonin effects. Schematic representation of lupus nephritis kidney injury at glomerular, proximal and distal tubules and of melatonin effects against lupus nephritis renal alterations. It is important to underline that this indoleamine is able to modulate differently the apoptotic pathway in glomerular and tubular cells. The red arrows indicate the effect of pristane injection, whereas the blue arrows denote the significant melatonin treatment effects. CAT: catalase; IL-6: interleukin-6; LN: lupus nephritis; SOD1: superoxide dismutase1; TGF-β1: tumor growth factor-beta1. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
